Oncosec Medical Stock EBITDA
| ONCSDelisted Stock | USD 0.06 0 3.63% |
OncoSec Medical fundamentals help investors to digest information that contributes to OncoSec Medical's financial success or failures. It also enables traders to predict the movement of OncoSec Stock. The fundamental analysis module provides a way to measure OncoSec Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OncoSec Medical stock.
OncoSec |
OncoSec Medical Company EBITDA Analysis
OncoSec Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current OncoSec Medical EBITDA | (35.92 M) |
Most of OncoSec Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OncoSec Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, OncoSec Medical reported earnings before interest,tax, depreciation and amortization of (35.92 Million). This is 104.09% lower than that of the Biotechnology sector and 135.86% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.92% higher than that of the company.
OncoSec EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OncoSec Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics of similar companies.OncoSec Medical is currently under evaluation in ebitda category among its peers.
OncoSec Fundamentals
| Return On Equity | -4.1 | |||
| Return On Asset | -0.93 | |||
| Current Valuation | 5.6 M | |||
| Shares Outstanding | 5.96 M | |||
| Shares Owned By Insiders | 28.01 % | |||
| Shares Owned By Institutions | 5.83 % | |||
| Number Of Shares Shorted | 192.06 K | |||
| Price To Earning | (3.12) X | |||
| Price To Book | 0.78 X | |||
| EBITDA | (35.92 M) | |||
| Net Income | (34.18 M) | |||
| Cash And Equivalents | 19.48 M | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 6.17 M | |||
| Debt To Equity | 0.76 % | |||
| Current Ratio | 4.51 X | |||
| Book Value Per Share | (1.85) X | |||
| Cash Flow From Operations | (32.14 M) | |||
| Short Ratio | 0.34 X | |||
| Earnings Per Share | (20.31) X | |||
| Target Price | 110.0 | |||
| Number Of Employees | 40 | |||
| Beta | 2.0 | |||
| Market Capitalization | 1.65 M | |||
| Total Asset | 21.88 M | |||
| Retained Earnings | (285.96 M) | |||
| Working Capital | 8.6 M | |||
| Current Asset | 29.42 M | |||
| Current Liabilities | 3.47 M | |||
| Z Score | -23.08 | |||
| Net Asset | 21.88 M |
About OncoSec Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |